Filing Details

Accession Number:
0000939767-21-000020
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-17 20:15:53
Reporting Period:
2021-02-12
Accepted Time:
2021-02-17 20:15:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
939767 Exelixis Inc. EXEL Biological Products, (No Disgnostic Substances) (2836) 043257395
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1692954 J. Patrick Haley C/O Exelixis, Inc.
1851 Harbor Bay Parkway
Alameda CA 94502
Evp, Commercial No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-02-12 45,000 $21.57 246,887 No 4 S Direct
Common Stock Disposition 2021-02-15 1,400 $21.91 245,487 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 F Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 23,539 Indirect By spouse
Common Stock 10,648 Indirect By 401(k)
Footnotes
  1. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.54 to $21.62. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.
  2. Includes 170,820 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
  3. Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 10, 2018, for which the Compensation Committee certified that Exelixis, Inc. had achieved the performance goal on December 4, 2019.
  4. Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 12, 2021.